Femasys Inc. (FEMY)
Femasys Inc., a biomedical company, focuses on women's healthcare market in the United States. The company develops permanent birth control solutions, such as FemBloc and FemChec; FemaSeed, an artificial insemination solution; FemCerv, a biopsy device for endocervical curettage; and FemEMB, a product candidate for endometrial sampling in support of uterine cancer detection testing. It also commercializes FemVue saline-air device in the United States, Europe, Canada, Japan, and internationally. The company offers its infertility products to obstetrics-gynecological physicians, related healthcare professionals, women's healthcare provider organizations, and reproductive endocrinologists. In addition, it provides non-surgical product technologies. Femasys Inc. was incorporated in 2004 and is based in Suwanee, Georgia.
$26.45M
Ms. Kathy Lee-Sepsick
27.00
Suwanee, GA
Jun 18, 2021
-1.42
$-0.84
5.49
6.47
-1,756.82%
-1.45
-0.35
2.15
25.51
5.93
-82.32%
-119.97%
Similar stocks (7)
Utah Medical Products, Inc.
UTMD
InfuSystem Holdings, Inc.
INFU
KORU Medical Systems, Inc.
KRMD
Pro-Dex, Inc.
PDEX
Milestone Scientific Inc.
MLSS
Precision Optics Corporation, Inc.
POCI
Nephros, Inc.
NEPH
ETF Exposure (2)
Vanguard Extended Market Index Fund Institutional Shares
VIEIX
0%
Vanguard Extended Market Index Fund
VXF
0%
Similar stocks (7)
Utah Medical Products, Inc.
UTMD
InfuSystem Holdings, Inc.
INFU
KORU Medical Systems, Inc.
KRMD
Pro-Dex, Inc.
PDEX
Milestone Scientific Inc.
MLSS
Precision Optics Corporation, Inc.
POCI
Nephros, Inc.
NEPH
ETF Exposure (2)
Vanguard Extended Market Index Fund Institutional Shares
VIEIX
0%
Vanguard Extended Market Index Fund
VXF
0%